About Mendel AI
Mendel.ai provides clinical trial-matching solutions. It uses artificial intelligence (AI) to help providers and institutions implement evidence-based treatment, including referrals to clinical trials. Mendel AI was founded in 2016 and is based in San Jose, California.
ESPs containing Mendel AI
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The EHR-based patient recruitment market focuses on utilizing electronic health record (EHR) data to identify and recruit eligible patients for clinical trials. This market offers a range of solutions that enable efficient and targeted patient recruitment based on factors such as medical history, demographics, and clinical characteristics. By using EHR-based patient recruitment solutions, research…
Mendel AI's Products & Differentiators
Optical Character Recognition technology
Research containing Mendel AI
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Mendel AI in 5 CB Insights research briefs, most recently on Aug 1, 2023.
Expert Collections containing Mendel AI
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Mendel AI is included in 4 Expert Collections, including Artificial Intelligence.
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Precision Medicine Tech Market Map
This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.
This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.
Latest Mendel AI News
Jul 19, 2022
Sailu Challapalli named as Chief Product Officer and Hylton Kalvaria named as Chief Commercial Officer July 19, 2022 09:00 AM Eastern Daylight Time SAN JOSE, Calif.--( BUSINESS WIRE )-- Mendel , the leading clinical artificial intelligence and natural language processing platform, today announced the expansion of its leadership team with two key C-suite hires: Sailu Challapalli as Chief Product Officer and Hylton Kalvaria as Chief Commercial Officer. The company continues to source exceptional individuals from the strongest organizations in healthcare and technology. Challapalli and Kalvaria bring significant experience to the Mendel team to aid the company’s strategic expansion. “We’re excited to welcome Sailu and Hylton to Mendel’s executive leadership team,” said Karim Galil, co-founder and CEO of Mendel. “Sailu and Hylton hail from some of the most important and disruptive real world evidence companies in the world. I’m thrilled to have them lead and grow our product, customer and commercial organizations.” Challapalli has nearly two decades of experience working in healthcare consulting, academic medical centers, and healthcare technology companies. Most recently, she served as the VP of Product Management at Flatiron Health, where she helped to scale its custom real world evidence data & analytic product line. Prior to Flatiron, Challapalli held various roles at Kyruus, in McKinsey & Company’s Healthcare Systems & Services practice, and at Columbia University Medical Center focused on leveraging healthcare technologies and data to improve patient access and quality of care. Kalvaria joins Mendel from Verana Health where he served as Chief Business Officer. At Verana, he built a world class commercial and delivery function including sales, marketing, partnerships and quantitative science teams. Kalvaria previously held a variety of roles at Flatiron Health and Genentech, both focused on the development and usage of high quality real world evidence for use across the healthcare industry. The healthcare industry faces immense challenges in parsing unstructured medical data that is highly valuable, but also extremely difficult and expensive to access. Mendel's solution unlocks 80% of the world's clinical data by leveraging contextual understanding to transform unstructured electronic medical record (EMR) data and clinical literature into comprehensive and compliant analytics-ready data. It abstracts data 27,000 times faster than the primarily manual methods most frequently used in clinical settings, and its output is reviewed and validated by a team of clinical experts to guarantee research-grade output. Mendel closed a $40 million Series B funding round in April from Oak HC/FT with participation from existing investor DCM. The company is poised for significant market expansion in 2022 and will be expanding headcount across offices in San Francisco Bay Area, New York City and Cairo, Egypt. For more information about Mendel visit Mendel.ai, and to see open positions visit Mendel.ai/careers . About Mendel Mendel is a machine that can read and understand medicine. Mendel Health is a for-profit corporation headquartered in San Jose, California, that uses novel AI technology to absorb clinical data in medical literature as well as patient health records, to unlock a wide range of Real World Data applications. For more information about Mendel, visit Mendel.ai . Contacts
Mendel AI Frequently Asked Questions (FAQ)
When was Mendel AI founded?
Mendel AI was founded in 2016.
Where is Mendel AI's headquarters?
Mendel AI's headquarters is located at 111 West St John Street, San Jose.
What is Mendel AI's latest funding round?
Mendel AI's latest funding round is Series B.
How much did Mendel AI raise?
Mendel AI raised a total of $60.2M.
Who are the investors of Mendel AI?
Investors of Mendel AI include Oak HC/FT Partners, BootstrapLabs, DCM Ventures, IndieBio, SOSV and 10 more.
Who are Mendel AI's competitors?
Competitors of Mendel AI include Autonomize, COTA, Dyania Health, Vasta Global, ConcertAI and 7 more.
What products does Mendel AI offer?
Mendel AI's products include Retina and 4 more.
Compare Mendel AI to Competitors
ScienceIO is a company that focuses on healthcare data management and artificial intelligence. The company offers services that transform medical text into enriched data, identify protected health information, and map medical terms in documents, all aimed at improving patient care. ScienceIO primarily serves the healthcare industry. It is based in Boston, Massachusetts.
Aetion operates as a healthcare analytics company. It provides decision-grade real-world evidence solutions to biopharma companies, payers, and regulatory agencies. It offers a platform that analyzes data from the real world to produce scientifically validated answers on treatments, effectiveness, and value. The company was founded in 2012 and is based in New York, New York.
Deep 6 AI provides clinical treatments to patients. It uses artificial intelligence and natural language processing on clinical data to find eligible patients for clinical trials. Its software accelerates patient recruitment and getting life-saving treatment to patients. Deep 6 AI was formerly known as Deep 6 Analytics. It was founded in 2016 and is based in Pasadena, California.
nference is a science-first software company that focuses on transforming unstructured data from electronic medical records (EMR) into powerful software solutions in the healthcare and life sciences industry. The company's main services include the development of software products that enable the synthesis of biomedical information, the creation of AI-enabled solutions for healthcare, and the provision of tools that unlock insights from structured and unstructured patient records. nference primarily sells to the healthcare ecosystem, with a focus on medical centers and biopharmaceutical companies. It was founded in 2013 and is based in Cambridge, Massachusetts.
Evidation operates as a multichannel health tracking platform. It enables users to connect with multiple appications to track everyday activity and earn rewards for steps, sleep, surveys, and more. The company was founded in 2012 and is based in San Mateo, California.
Ontada is a company focused on oncology data, research, and technology within the healthcare industry. The company offers solutions that provide precise insights for more informed care in oncology, and technologies that enable critical therapies to reach more patients. Ontada primarily serves the healthcare sector, specifically providers and innovators in oncology. It was founded in 2021 and is based in Atlanta, Georgia. Ontada operates as a subsidiary of McKesson.